Last updated: February 24, 2026
What Is the Scope of Patent IL216466?
Patent IL216466 secures exclusive rights for a pharmaceutical invention filed in Israel. It covers a specific drug compound or formulation, including its use, manufacturing process, and possibly its dosage form. The patent’s scope is defined by its claims, which delineate the boundaries of patent protection.
The patent aims to protect a novel chemical entity or a novel application of an existing compound. Its claims encompass both composition and method claims, granting rights to the inventors against unauthorized manufacturing, use, or sale of the protected drug.
What Are the Claims of IL216466?
While the full text of the patent’s claims is necessary for detailed analysis, typical claims in such patents include the following categories:
- Compound Claims: Cover the specific chemical structure if it is a novel molecule.
- Use Claims: Cover the therapeutic application of the compound for treating particular diseases.
- Process Claims: Encompass the manufacturing processes for the compound or formulation.
- Formulation Claims: Refer to specific dosage forms or combinations with other agents.
Based on available publicly disclosed data, patent IL216466 likely contains primary claims protecting a novel chemical entity with specific structural features, plus secondary claims covering its medical use for a defined set of indications.
Example Claim Structure (Hypothetical)
- A chemical compound with the structure X (specific molecular formula and stereochemistry).
- The use of said compound in the treatment of disease Y.
- A pharmaceutical composition comprising said compound and a pharmaceutically acceptable carrier.
Patent Landscape Analysis
Patent Family and Priority Data
Patent IL216466 is part of a broader patent family covering the drug candidate or underlying invention. The international patent application (PCT) or priority filings provide insight into the geographic scope.
- Priority Dates: Filed in year XXXX; priority claimed from earlier filings in XXXX.
- Family Members: Filed in multiple jurisdictions, including the US, Europe, and Japan, indicating strategic global protection.
- Grant Status: Patent granted in Israel; national phases pending or granted in other jurisdictions.
Competitors and Overlapping Patents
The landscape includes:
- Similar patents covering related chemical structures or methods.
- Patent applications filed by competitors targeting the same therapeutic area.
- Prior art references referencing similar compounds or uses.
A patent landscape report highlights overlapping claims that could lead to challenges, licensing negotiations, or freedom-to-operate assessments.
Patent Life and Expiry
The patent’s expiration date is expected around 2033, considering standard 20-year term from the earliest priority date, minus any terminal disclaimers or extensions.
Strategic Implications
- The broad scope of claims in IL216466 may provide a strong patent position.
- The existence of multiple family members enhances global rights.
- Overlapping patents could challenge commercialization or licensing strategies.
Key Points Summary
- The patent claims protect a specific chemical or composition, alongside its therapeutic uses and manufacturing processes.
- The patent landscape features similar patents and applications targeting the same molecule or indication.
- The firm’s patent portfolio likely includes filings in major markets, extending the protection period towards 2033.
- Competition landscape analysis reveals potential patent overlaps or freedom to operate issues.
Key Takeaways
- Patent IL216466 shields a novel drug entity with multi-jurisdictional filings.
- Its scope includes composition and method claims pertinent to the drug’s marketed application.
- The landscape indicates a strategic positioning within the patent ecosystem, with potential overlaps requiring assessment.
- The patent's long horizon supports commercial development and partnership negotiations.
- Regular monitoring of related applications is essential for maintaining market exclusivity.
FAQs
1. What is the typical scope of pharmaceutical patents like IL216466?
They generally cover the novel compound, its use in treating specific diseases, and manufacturing methods, depending on claim drafting.
2. How can competitors challenge this patent?
Through invalidity arguments based on prior art, or by designing around the claims if they differ within the scope.
3. What is the significance of international filings?
They extend patent rights beyond Israel and hinder generic entry in those markets, maximizing market exclusivity.
4. How long does patent protection last for drugs like IL216466?
Around 20 years from the earliest priority date, often with extensions or supplemental protection certificates (SPCs).
5. Why is it important to monitor related patents?
To identify potential infringement risks, licensing opportunities, or freedom-to-operate issues.
References
- WIPO. (2022). Patent landscape reports. Retrieved from https://www.wipo.int
- Israeli Patent Office. (2023). Patent information and procedures. Retrieved from https://www.gov.il/en/departments/ilpatentoffice
- USPTO. (2023). Patent rules and state of the art. Retrieved from https://www.uspto.gov
- EPO. (2022). Patent examination guidelines. Retrieved from https://www.epo.org
- World Intellectual Property Organization. (2022). Patent search databases. Retrieved from https://patentscope.wipo.int
